Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03582033
Title A Safety Study of SEA-BCMA in Patients With Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine Palo Alto California 94304 United States Details
Rocky Mountain Cancer Centers - Aurora Aurora Colorado 80012 United States Details
University of Miami Miami Florida 33136 United States Details
Holden Comprehensive Cancer Center / University of Iowa Iowa City Iowa 52242 United States Details
University of Kansas Cancer Center Westwood Kansas 66205 United States Details
Washington University in St Louis Saint Louis Missouri 63110 United States Details
Weill Cornell Medicine New York New York 10065 United States Details
James P. Wilmot Cancer Center / University of Rochester Medical Center Rochester New York 14642 United States Details
Willamette Valley Cancer Institute and Research Center Eugene Oregon 97401 United States Details
Texas Oncology - Austin Midtown Austin Texas 78705 United States Details
Texas Oncology - Northeast Texas Tyler Texas 75702 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Research Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field